# Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial

> **NCT02086006** · NA · COMPLETED · sponsor: **Elixir Medical Corporation** · enrollment: 16 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** DESolve Novolimus Eluting Bioresorbable Coronary Scaffold

## Key facts

- **NCT ID:** NCT02086006
- **Lead sponsor:** Elixir Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2016-10
- **Final completion:** 2017-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02086006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02086006, "Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02086006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*